دانلود کتاب Hormone antagonists

فهرست مطالب :

PREFACE\nCONTENTS\nSECTION 1: STEROID HORMONE ANTAGONISTS\nSTEROID AGONISTS AND ANTAGONISTS: MOLECULAR CONFORMATION, RECEPTOR BINDING AND ACTIVITY\nANTIHORMONAL ACTIVITIES OF STEROIDS WITH MODIFIED RINGS A OR B\nANTAGONISM OF STEROID HORMONES BY SPECIFIC ANTIBODIES\nANTAGONISM OF STEROID HORMONE ACTION BY INTERFERENCE OF RECEPTOR FUNCTION WITH LOW MOLECULAR WEIGHT INHIBITORS\nANTI-STEROIDS AND ANIMAL BEHAVIOUR : A REVIEW\nAGONISTIC AND ANTAGONISTIC PROPERTIES OF CLOMIPHENE\nHYDROXYLATED ANTIOESTROGENS: NEW PHARMACOLOGICAL PROBES TO INVESTIGATE OESTROGEN AND ANTIOESTROGEN ACTION\nBiological Actions and Binding Properties of a New Estrogen Antagonist\nBINDING PROPERTIES AND LIGAND SPECIFICITY OF AN INTRACELLULAR BINDING SITE WITH SPECIFICITY FOR SYNTHETIC OESTROGEN ANTAGONISTS OF THE TRIPHENYLETHYLENE SERIES\nESTROGEN RECEPTOR BINDING PARAMETERS OF THE HIGH AFFINITY ANTIESTROGEN ³H-H1285\nPOTENTIAL ANTIOESTROGENIC AND ANTITUMOUR MECHANISMS OF TAMOXIFEN ACTION IN BREAST CANCER\nANTI-TUMOR ACTION OF NON-STEROIDAL ANTIESTROGENS\nPROGESTERONE INHIBITION OF NUCLEAR ESTROGEN RECEPTOR RETENTION\nADVANCES IN THE STUDY OF ANTIPROGESTATIONAL AGENTS\nPHARMACOLOGICAL AND CLINICAL EFFECTS OF ANT IANDROGENS\nMECHANISM OF ACTION OF A STEROIDAL ANTI-ANDROGEN TSAA-291, 16B-ETHYL-176-H YDROXYESTR-4-EN-3-ONE\nSTRUCTURE-AFFINITY RELATIONSHIP OF ANTIMINERALOCORTICOID ACTIVE STEROIDS\nPROGESTIN ANTAGONISM OF ALDOSTERONE ACTION IN THE KIDNEY\nCLINICAL PHARMACOLOGY AND THERAPEUTIC USE OF ALDOSTERONE ANTAGONISTS\nANTIGLUCOCORTICOIDS: DIFFERENTIAL ANTAGONISM OF IN VIVO RESPONSES TO DEXAMETHASONE\nANTAGONISM OF GLUCOCORTICOID ACTION IN VIVO\nDISCRIMINATION BETWEEN GLUCOCORTICOID AGONISTS AND ANTAGONISTS BY MEANS OF RECEPTOR BINDING STUDIES\nANTAGONISM OF GLUCOCORTICOID ACTION BY INSULIN\nINHIBITION OF ADRENAL STEROID BIOSYNTHESIS BY METYRAPONE\nSECTION 2: PEPTIDE HORMONE ANTAGONISTS\nSTRUCTURAL, CONFORMATIONAL AND DYNAMIC CONSIDERATIONS IN THE DEVELOPMENT OF PEPTIDE HORMONE ANTAGONISTS\nINHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM\nANTI-PROLACTIN AND ANTI-GROWTH HORMONE RECEPTOR ANTIBODIES, AND THEIR USE AS ANTI-HORMONAL AGENTS\nCLINICAL APPLICATIONS OF PROLACTIN LOWERING DRUGS\nRECEPTOR ANTAGONISTS OF THE ACTIONS OF GASTROINTESTINAL PEPTIDES ON PANCREATIC ACINAR CELLS\nGASTHIN ANTAGONISM\nANTIGONADAL EFFECTS OF GONADOTROPIN-RELEASING HORMONE AND AGONIST ANALOGS\nANTAGONISTS OF HYPOTHALAMIC REGULATORY PEPTIDES AND DOPAMINE\nLUTEINIZING HORMONE RELEASING HORMONE ANALOGS AS ANTIHORMONES\nANTIGONADOTROPIC, ANTISTEROIDOGENIC AND ANTISTEROIDAL ACTIVITIES OF AGONIST ANALOGS OF LUTEINIZING HORMONERELEASING HORMONE AS REVEALED BY THEIR ANTIREPRODUCTIVE ACTIVITIES\nSECTION 3: MISCELLANEOUS HORMONES AND ANTAGONISTS\nHORMONAL INHIBITION OF ADENYLATE CYCLASE: A POSSIBLE MECHANISM FOR PHYSIOLOGICAL ANTAGONISM\nNALOXONE AND NALTREXONE: Endorphin Antihormones\nANTIHISTAMINES\nX-RAY CRYSTALLOGRAPHIC STUDIES OF THYROID HORMONE, ANALOGUE AND COMPETITOR BINDING INTERACTIONS WITH HUMAN SERUM PREALBUMIN\nANTIPHEROMONES?\nAUTHOR INDEX\nSUBJECT INDEX